Myofilament Alterations Associated with Human R14del-Phospholamban Cardiomyopathy
Phospholamban (<i>PLN</i>) is a major regulator of cardiac contractility, and human mutations in this gene give rise to inherited cardiomyopathies. The deletion of Arginine 14 is the most-prevalent cardiomyopathy-related mutation, and it has been linked to arrhythmogenesis and early deat...
Main Authors: | Mohit Kumar, Kobra Haghighi, Sheryl Koch, Jack Rubinstein, Francesca Stillitano, Roger J. Hajjar, Evangelia G. Kranias, Sakthivel Sadayappan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/3/2675 |
Similar Items
-
Impaired Right Ventricular Calcium Cycling Is an Early Risk Factor in R14del-Phospholamban Arrhythmias
by: Kobra Haghighi, et al.
Published: (2021-06-01) -
Cardiac myosin activation in the treatment of congestive heart failure: New therapeutic options and review of literature
by: Arroj Ali, et al.
Published: (2021-01-01) -
Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil
by: Edgardo Kaplinsky, et al.
Published: (2018-04-01) -
Omecamtiv mecarbil in precision-cut living heart failure slices: A story of a double-edged sword
by: Jorik H. Amesz, et al.
Published: (2023-09-01) -
The myosin activator omecamtiv mecarbil improves wall stress in a rat model of chronic aortic regurgitation
by: Bachar El Oumeiri, et al.
Published: (2021-08-01)